Literature DB >> 29967802

Macrophage Functions and Regulation: Roles in Diseases and Implications in Therapeutics.

Kebin Hu1,2, Yang Jin3, Zissis Chroneos4, Xiaodong Han5, Hao Liu6, Ling Lin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29967802      PMCID: PMC6008777          DOI: 10.1155/2018/7590350

Source DB:  PubMed          Journal:  J Immunol Res        ISSN: 2314-7156            Impact factor:   4.493


× No keyword cloud information.
Macrophages, as a key element in innate immunity, play an important role in the first-line defense against pathogens and modulating inflammatory responses. From the traditional point of view, tissue macrophages are differentiated from bone marrow myeloid progenitor-derived monocytes in the circulation and undergo a fine-regulated process of adaption to the local tissue microenvironment [1]. However, over the past decade, mounting evidence has demonstrated that macrophages are also derived from embryonic York sac and fetal liver and become a self-maintaining population residing locally and performing organ-specific functions [2]. Macrophages are not homogenous and consist of variably mixed populations, such as liver Kupffer cells and brain microglial cells that carry out specific functions in the local microenvironment [3]. In response to various physiological or pathological cues, macrophages display an extended life span and acquire different functional phenotypes through polarization that are generally categorized into two broad but distinct subsets as either classically activated (M1) or alternatively activated (M2). In general, M1 macrophages have high motility and promote inflammation and damage through a combination of transcription factors such as NF-κB, whereas M2 macrophages help to resolve inflammation and promote tissue remodeling [4]. Notably, M1 and M2 only represent two extremes of macrophage polarization, and most differentiated macrophages fall into a full spectrum of various polarization states between M1 and M2. In addition, macrophage polarization is a dynamic process and macrophages can switch their phenotypes between M1 and M2 in different pathological conditions [5]. Nevertheless, sustained macrophage infiltration in face of injury eventually becomes pathological and causes distorted repair and remodeling, leading to irreversible tissue destruction and disease progression and deterioration. Thus, better understanding of the regulation of macrophage differentiation and polarization, as well as their roles in disease pathogenesis, will contribute to the development of selective and effective therapies. In this specific issue, fourteen quality manuscripts were selected for publication from a large number of submissions covering various topics of macrophage functions and regulation, as well as their roles in diseases and therapeutics. Ten of these publications are review articles reflecting the current status of knowledge and advances in understanding macrophage functions and regulation. L. Parisi et al. provided a comprehensive review regarding the role and regulation of M1-like (killers) and M2-like (builders) macrophages in various chronic diseases including cancers, type 2 diabetes, atherosclerosis, and periodontitis. They also discussed therapeutic approaches using cytokine antagonists and miRNAs. J. Yin et al. highlighted the current understanding of microglia and macrophage functions and differentiation in CNS homeostasis, autoimmunity, and cancer. Other review articles are more focused with emphasis on an individual disease, molecule, or pathway. J. Shi et al. discussed the roles of macrophage subsets in bowel anastomotic leakage and healing. L. Shao et al. summarized the perspectives and potential targets of macrophage polarization in cerebral aneurysm, and L. Zhu et al. reviewed the roles of members of the phospholipase C family in macrophage-mediated inflammation. T.S. Kapellos et al. updated the current knowledge regarding macrophage dysfunction in chronic obstructive pulmonary disease with a focus on the well-known resident alveolar macrophages, whereas, J. Schyns et al. illuminated the important role of the less-studied lung interstitial macrophages. Of note, there are two review articles about macrophage tolerance and regulation from R. Huber et al. and R. Ocaña-Guzman et al. with focus on TNF and inhibitory receptors, respectively. H. Liao et al. provided an interesting retrospective literature analysis regarding the role of macrophage iNOS activity in the therapeutic effect of Huangqi, a traditional Chinese medicine, on diabetic nephropathy. The remaining four accepted manuscripts are research articles of translational significance using various patient samples or animal models to study macrophage functions and regulation. M. Yamashita et al. examined the expression pattern of CD163-positive macrophages in lung biopsy samples from patients with idiopathic interstitial pneumonias. I.A. da Silva et al. investigated the role of the platelet-activating factor in modulating the tumor-associated macrophage phenotype, and W.R. Shen et al. demonstrated the potential therapeutic role of targeting osteoclast formation in LPS-induced bone loss. Y.M. Flores-Martinez et al. established a rat model of Parkinson's disease with classical microglia activation, neuroinflammation, and degeneration. These research articles all highlighted the important role of macrophage functions and regulation in disease pathogenesis and therapeutics. In summary, these articles illuminate the role and regulation of macrophage function and differentiation in the pathogenesis and therapeutics of various diseases, and provide guidance for future research on macrophage functions and development of selective and efficient therapeutics.
  5 in total

1.  Fate mapping analysis reveals that adult microglia derive from primitive macrophages.

Authors:  Florent Ginhoux; Melanie Greter; Marylene Leboeuf; Sayan Nandi; Peter See; Solen Gokhan; Mark F Mehler; Simon J Conway; Lai Guan Ng; E Richard Stanley; Igor M Samokhvalov; Miriam Merad
Journal:  Science       Date:  2010-10-21       Impact factor: 47.728

Review 2.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

Review 3.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 4.  Tissue-resident macrophages.

Authors:  Luke C Davies; Stephen J Jenkins; Judith E Allen; Philip R Taylor
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

5.  Tissue-type plasminogen activator modulates macrophage M2 to M1 phenotypic change through annexin A2-mediated NF-κB pathway.

Authors:  Ling Lin; Kebin Hu
Journal:  Oncotarget       Date:  2017-10-04
  5 in total
  6 in total

1.  High-Expressed Macrophage Scavenger Receptor 1 Predicts Severity Clinical Outcome in Transplant Patient in Idiopathic Pulmonary Fibrosis Disease.

Authors:  Mingfeng Zheng; Tian Tian; Jialong Liang; Shugao Ye; Jingyu Chen; Yong Ji
Journal:  J Immunol Res       Date:  2021-01-31       Impact factor: 4.818

Review 2.  Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma.

Authors:  Owen Ngalamika; Sody Munsaka
Journal:  J Immunol Res       Date:  2020-11-21       Impact factor: 4.818

3.  Generation of resolving memory neutrophils through pharmacological training with 4-PBA or genetic deletion of TRAM.

Authors:  RuiCi Lin; Ziyue Yi; Jing Wang; Shuo Geng; Liwu Li
Journal:  Cell Death Dis       Date:  2022-04-13       Impact factor: 8.469

4.  Lack of CD8+ T-cell co-localization with Kaposi's sarcoma-associated herpesvirus infected cells in Kaposi's sarcoma tumors.

Authors:  Salum J Lidenge; For Yue Tso; Owen Ngalamika; Jaydeep Kolape; John R Ngowi; Julius Mwaiselage; Charles Wood; John T West
Journal:  Oncotarget       Date:  2020-04-28

5.  CD206+ M2-Like Macrophages Are Essential for Successful Implantation.

Authors:  Yosuke Ono; Osamu Yoshino; Takehiro Hiraoka; Erina Sato; Yamato Fukui; Akemi Ushijima; Allah Nawaz; Yasushi Hirota; Shinichiro Wada; Kazuyuki Tobe; Akitoshi Nakashima; Yutaka Osuga; Shigeru Saito
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

6.  Quanzhenyiqitang Reverses LPS-Induced Inflammation via Inhibiting PYK2/p38MAPK/HDAC2/CK2 Signaling Pathway in Rat Alveolar Macrophage.

Authors:  Ke-Qiang Chen; Da-Zhi Li; Zhi-Bin Chen; Chuan-Lin Zhang; Bin-Can Wang; Chun-E Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-10       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.